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ABSTRACT We are presented a 35-year-old patient with no previous relevant medical history who was admitted to
the emergency department for fever, altered mental status and diffuse abdominal pain. Initial evaluation failed to
demonstrate the presence of thoracic or abdominal deep infection. The clinical course was marked by a deterioration of
the neurological condition. The cerebral MRI showed diffuse and extensive involvement of the brainstem and cerebellar
hemispheres associated with hydrocephalus consistent with tuberculous meningoencephalitis. Antituberculous therapy
was started, but no clinical improvement was achieved.
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Introduction
Mycobacterium tuberculosis is responsible for approximately 10
million new cases of tuberculosis and 1,3 million deaths annu-
ally [1]. Tuberculous meningitis is considered the most severe
form of this infection. Tuberculous meningitis disproportion-
ately affects children and HIV patients [2]. The clinical onset
of tuberculous meningitis is indolent, which makes diagnosis
difficult. Its treatment regimens are still uncertain.
Case report
This is a 35-year-old woman with no previous chronic diseases.
She was admitted to the emergency department for fever and
altered mental status and personality change 24 hours before
hospital admission. She had been previously evaluated by her
family doctor for diffuse abdominal pain, vomiting and diar-
rhoea and received ten days of oral ciprofloxacin twice daily
with no clinical improvement. Her recent medical history also
revealed the presence of mechanic lumbar pain with a lumbar
scanner only showing signs of arthrosis.
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Upon admission at the emergency department, she was
febrile, blood pressure 120/70 mmHg and tachycardia. The
neurological examination revealed Glasgow coma score was
14/15 and lethargy but no neck stiffness or any other focal neu-
rological sign. The abdomen was diffusely painful, with no
masses and the lumbar palpation from L1 to L5 was painful. The
cardiorespiratory exam was normal.
Laboratory investigations revealed the presence of inflam-
matory syndrome, neutrophil hyperleukocytosis (14900 /mm3,
neutrophils 60%), protein C reactive (30 mg/L). Coagulation,
electrolytes as well as liver and renal function tests were within
the normal range. A complete body scanner aiming at detecting
a thoracic or abdominal deep infection was performed, but it
was normal.
The patient was transferred to the internal medicine depart-
ment for further investigations. Upon arrival and considering
the persistence of altered mental status, a lumbar puncture was
performed. It showed 190 white cells/mm3 and 71% lympho-
cytes, hyperproteinorachie (1.81 g/L) and hypoglycorachie (1.4
mmol/L). Gram stain was PCR on CSF for HSV, VZZ, CMV, EBV
and measles were negative as well as the serologies for Lyme
disease, CMV, HSV, VZV and EBV. Blood cultures were negative.
The electroencephalogram showed no abnormal activity, and
the brain scanner was normal.
The diagnosis of bacterial meningitis probably beheaded by
recent antibiotic treatment was evoked, and empiric treatment
with cefotaxime (2g every 4 h) and vancomycin (22.5 mg/kg
q12h) associated to acyclovir was started. However, 72 hours
after hospital admission, the patient was still febrile, developed
projecting vomiting and Glasgow was 8/15. The patient was
intubated and sedated and transferred to the intensive care unit.
The brain scanner showed the presence of hydrocephaly in set-
ting of a clinical picture consistent with intracranial hyperten-
sion. An external ventricular derivation was placed. This one
was surgically changed three times owing to obstruction. In-
tracranial hypertension was controlled, and sedation was slowly
discontinued. However, the neurological course was marked
by the absence of awakening state and stereotyped extension
of the four limbs to pain. The patient was sent for a brain scan-
ner in order to rule out bleeding or sinus thrombosis, but it
only showed the persistence of diffuse and bilateral cerebral
edema. The investigations were completed but a cerebral and
lumbar magnetic resonance. The cerebral MRI showed diffuse
and extensive involvement of the brainstem and cerebellar hemi-
spheres associated with hydrocephalus consistent with tubercu-
lous meningoencephalitis (Fig 1, 2a, 2b, 3). The lumbar magnetic
resonance study demonstrated L1 body edema and hyperinten-
sity consistent intradural empyema (Fig 4, 5).
PCR for TB in the LCR and endotracheal secretions were
positive as well as Quantiferon. Immediately treatment with Iso-
niazid, Rimphanpicine, Ethambuthole and Pyrazinamide was
started. However, seven days after treatment, no clinical im-
provement was noted. The risk of a vegetative state and severe
sequelae was discussed with the patient’s relatives who decided
to stop active treatment. The patient passed away 48 hours later.
During the interview the relatives, they stated the patient had
been working in a refugee centre four months before
Discussion
Central nervous system (CNS) tuberculosis (TB) includes three
clinical categories: tuberculous meningitis, intracranial tuber-
culoma, and spinal tuberculous arachnoiditis. These categories
are frequently encountered in regions where the incidence of
TB is high, and the prevalence of post-primary dissemination
is common among children and young adults [2]. Tuberculous
meningitis accounts for about 1 percent of all cases of TB and
5 percent of all extrapulmonary disease in immunocompetent
individuals [3]. Risk factors include: travel to/residence in a
country with high TB prevalence, HIV infection, children, el-
derly, alcoholism, drug abuse, homelessness and exposure to
person with pulmonary TB as in our case.
Early recognition of tuberculous meningitis is of paramount
importance because the clinical outcome depends significantly
upon the stage at which therapy is initiated. Empiric antitubercu-
lous therapy should be started immediately in any patient with
meningitis syndrome and cerebrospinal fluid (CSF) findings of
low glucose concentration, elevated protein, and lymphocytic
pleocytosis if there is evidence of TB elsewhere, either clinically
or historically, or if prompt evaluation fails to establish an alter-
native diagnosis as in the case presented.
The patient presented with the so-called meningitic phase
follows with more pronounced neurologic features in this case
vomiting, lethargy and confusion, but meningismus, protracted
headache, and varying degrees of cranial nerve and long-tract
signs could also be described. Typically, the CSF formula shows
elevated protein and lowered glucose concentrations with a
mononuclear pleocytosis as in our case which was initially con-
sidered the result of the previous antibiotics treatment and lead-
ing to the delay in diagnosis. Besides, early in the course of
disease, the CFS formula is often atypical with only a few cells
or with polymorphonuclear leukocyte (PMN) predominance.
These cases usually quickly develop a lymphocytic cellular pre-
dominance if subsequent CSF examinations are performed [4].
Another important useful diagnostic tool is the measurement
of the CSF adenosine deaminase (ADA) [4], but unfortunately it
was not considered. Its result should be carefully interpreted as
elevated CSF ADA level may also be observed in the setting of
bacterial infections [5] without clear threshold to distinguish TB
meningitis from bacterial meningitis.
The clinical and biological picture was erroneously inter-
preted as a bacterial meningoencephalitis leading to clinical
worsening and delay treatment and diagnosis. Differential di-
agnosis is comprehensive and includes other causes of basilar
meningitis particularly sarcoidosis, endemic fungi, neurobrucel-
losis and leptomeningeal carcinomatosis.
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Antituberculous therapy should be promptly started based
on strong clinical suspicion and should not be delayed until
bacteriologic proof has been obtained. The patient’s clinical out-
come depends largely on the stage at which therapy is initiated.
Worse outcomes result from delay than from inappropriate ther-
apy as long as efforts are continued to confirm the diagnosis as
in our case
Conclusion
The diagnosis of tuberculous meningitis is challenging and the
outcomes poor when the diagnosis and treatment are delayed.
Learning points
• Tuberculous meningitis should be considered when the
CSF shows low glucose concentration, elevated protein, and
lymphocytic pleocytosis if there is evidence of TB elsewhere,
either clinically or historically, or if prompt evaluation fails
to establish an alternative diagnosis.
• Antituberculous therapy should be promptly started based
on strong clinical suspicion and should not be delayed until
bacteriologic proof has been obtained.
• Epidemiological data collection is of huge importance in
the evaluation of patient with suspected meningitis.
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